Impact of remdesivir on liver function: A comparative study of diabetic and non-diabetic COVID-19 patients

Endocrine and Metabolic Science, Journal Year: 2025, Volume and Issue: unknown, P. 100237 - 100237

Published: March 1, 2025

Language: Английский

Long-Term Impairment of Working Ability in Subjects under 60 Years of Age Hospitalised for COVID-19 at 2 Years of Follow-Up: A Cross-Sectional Study

Viruses, Journal Year: 2024, Volume and Issue: 16(5), P. 688 - 688

Published: April 26, 2024

Coronavirus disease 2019 (COVID-19) can lead to persistent and debilitating symptoms referred as Post-Acute sequelae of SARS-CoV-2 infection (PASC) This broad symptomatology lasts for months after the acute impacts physical mental health everyday functioning. In present study, we aimed evaluate prevalence predictors long-term impairment working ability in non-elderly people hospitalised COVID-19.

Language: Английский

Update on efficacy of the approved remdesivir regimen for treatment of COVID-19: a systematic review with meta-analysis and trial sequential analysis of randomized controlled trials

Current Medical Research and Opinion, Journal Year: 2024, Volume and Issue: 40(8), P. 1277 - 1287

Published: June 8, 2024

Background Efficacy of remdesivir for COVID-19 remains unclear. We updated our published systematic review to better inform on the use COVID-19.

Language: Английский